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Abstract: To determine if AE virus disease in laying hen farms in Algeria and to know the 
economic impact of vaccination, During the period from May 2014 to June 2015 ,sixteen farms with 
history of lowered egg productivity. 480 serums samples were tested for antibodies using commercial 
(Elisa) kits. For statistical analysis, Mann-Whitney test was for economic analysis, costs-benefits. 
Serological results revealed a percentage of 81.25% of positive seroconversion. At 5% degree of 
significance, economic analysis showed that vaccination against AE virus engenders economic 
benefits.  
 




Avian encephalomyelitis (AE) virus infection in laying bird causes unapparent 
infection or drops in egg production. From December 2013 to March 2014, a preliminary 
study has been conducted to reveal the suspected etiologies causing egg drop. For this 
reason, a survey has been performed in order to know the opinion of the veterinary 
practitioners and their knowledge about the probable etiologies and also the common applied 
vaccination programs. For this, a number of 400 veterinary practitioners have been selected 
randomly among 7000 ones working in the different farms of the Algeria. The results showed 
that 88% of the questioned veterinary practitioners say that viral etiologies are the main 
causes of egg drop. The aim of this study is to demonstrate the presence of the avian 
encephalomyelitis (AE) virus disease in laying hen farms of Algeria from one side, and to 
analyse the economic impact of vaccination against that virus from the other side. 
 
MATERIAL AND METHODS 
 
From May 2014 to June 2015, 16 laying hen farms spread across the country. These 
farms have a capacity of 4800 up to 130,000 laying hens, observed by sentinel veterinarian 
after an egg drop; a data sheet for the laying hens was established containing the following 
information:The capacity strains, vaccination programs applied, accidents laying observed 
(percentage drop, external appearance of eggs), the associated clinical symptoms, autopsy 
examinations and mortality rates recorded during an episode of the egg drop.  
Blood samples at the wing vein according to the method of Campbell (1995) were 
performed on 15 hens per farm right at the moment of the egg drop (S1) and another sample 
made three weeks later (S2), a total of 450 serums were made. Technically, a volume of 3 
ml of blood / chicken was taken at the wing vein and collected in dry tubes and directly 
centrifuged (3000 rpm / min, 6 min).  
After centrifugation, a volume of 300ul plasma was collected using a capillary 
pipette and divided into two Eppendorf tubes labeled for each sample and kept cold in a 
freezer (-20 ° C) until the serological analysis performed at the analytical laboratory (LAB-
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VET in partnership with the laboratory of BIO CHENE-VERT-France). The kits are 
supplied by Bio Check (Check Bio BV Holland), they contain 05 plates and all reagents 
required (ready to use). Each sample was diluted to 1/500 1ul adding 0.5 ml dilution buffer. 
Measuring results of the ELISA test is performed with a microplate reader: with a 
spectrophotometer at 405 nm filter. Mann- 
Whitney test is a nonparametric test and it is based on the comparison between the 
medians of the two samples. The null hypothesis (H0) is given by: H0: Median 1 = Median 
2. The acceptance of the null hypothesis would signify that the distribution of the variable 
of interest (virus concentration in serums) is the same in the two serological samples, and 
then the two samples come from the same population. For economic analysis, costs-benefits 
comparison approach was used in order to evaluate gains and losses due to vaccination 
against AE virus. Currency conversion from Algerian Dinars (DZA) to Euro (€) was done 
relying on the current exchange rate (1 € = 120 DZA).The sample size of laying hens that 
were under vaccination is 10,000 hens.  
The applied vaccine consists of bottle that contains 1000 doses and that costs about 
30 €. The vaccine against the AE is made by eye drop and without a booster at 12 weeks of 
age. Since one person is sufficient to vaccinate 1000 pullets, 10 people under the direction 
of a veterinarian were given the task to vaccinate the whole sample.  
Estimation of benefits was based on the evaluation of losses in the absence of 
vaccination. For eggs, the gain calculation was based on the difference between the actual 
laying hens and the theoretical curve multiplied by the unit price of egg which is 0.06 € and 
that represents the selling price of the market during the study period. The eggs production 
shortfall represents the amount of eggs that have been laid by individuals during a clinical 
episode of AE multiplied by the consumption egg price estimated at 0.06 €. 
 According to the veterinary practitioners questioned in the preliminary study, the 
number of eggs laid during the manifestation of an egg drop episode is estimated around 
9500 eggs for each 10,000 hens. Since reducing the number of subjects who would have 
died by the AE during the clinical phase of the disease can be considered as a benefit, this 
later was calculated by multiplying the number of deaths by the unit price of hen estimated 
at € 3.75. For the 16 studied farms, the average mortality rate attributed to AE was estimated 










Positive serology Negative serology 
Number % Number % 
East 3 2 66,67% 1 33,33% 
Center 11 9 81,82% 2 18,18% 
West 2 2 100,00% 0 0,00% 
Total 16 13 81,25% 3 18,75% 
 
Agricultura – Ştiinţă şi practică                                         no. 1 – 2 (101-102)/2017                                         Agriculture - Science and Practice  
- 118 - 
 
Table 2 






Positive serology Negative serology 
Number % Number % 
<1 week 1 0 0,00% 1 100,00% 
1-2 weeks 5 5 100,00% 0 0,00% 
2-3 weeks 6 5 83,33% 1 16,67% 
> 3 weeks 4 3 75,00% 1 25,00% 
Total 16 13 81,25% 3 18,75% 
Table 3  
The seroprevalence of AE depending on the rate of egg drop 
 




Positive serology Negative serology 
Number % Number % 
5-15% 9 9 100,00% 0 0,00% 
> 15% 7 4 57,14% 3 42,86% 
Total 16 13 81,25% 3 18,75% 
      
 
Table 4 














F1 No 9428 496 Positive                 0,0001 
F2 No 427 2315 Positive 0,144 
F3 Yes 4177 4643 Positive 0,3 
F4 No 8041 8236 Positive 0,772 
F5 No 3949 6854 Positive 0,068 
F6 No 120 3983 Positive 0,001 
F7 No 4723 7829 Positive 0,003 
F8 No 5250 5970 Positive 0,3 
F9 Yes 121 3194 Positive 0,0001 
F10 No 508 7542 Positive 0,0001 
F11 Yes 2646 3990 Positive 0,147 
F12 No 471 471 Negative 0,135 
F13 Yes 294 65 Negative 0,008 
F14 No 3781 6338 Positive 0,031 
F15 No 4837 5553 Positive 0,561 
F16 No 139 124 Negative 0,22 
 
Among the 16 farms selected randomly, 11 were from the center of the country, 3 
from the east and 2 from the west. Results concerning the seroprevalence of AE depending 
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on the region, the duration of egg drop, clinical symptoms and on the rate of egg drop are 
presented in tables 1, 2, 3 and 4 respectively. These tables allow us to highlight different 
results concerning the AE in Algeria. Concerning regional side, table 1 shows that positive 
serology is much higher in the west and the center of the country.  
Concerning the duration of egg drop, table 2 shows that manifestation of AE in 
breeding laying hens causes egg drop for periods varying from 1 week to even more than 3 
weeks. For farms with egg drop duration less than 1 week, all of them are serologically 
negative. However, for farms with egg drop duration varying between 1 and 2 weeks, all of 
them are serologically positive. Positive serology is also high for periods varying between 2 
and 3 weeks, and even for more than 3 weeks. 
 
Table 5 
Costs-Benefits analysis results of vaccination against AE 
 
Costs Benefits 
More expenses  Price in € More products  Price in € 
Cost of vaccine  
300 Eggs production gain 570 (10,000 doses) 
Cost of Vaccination 
(10,000 laying hens) 700 Mortality reduction 1875 
Less expenses  Price in € Less expenses  Price in € 
None 0 Treatment reduction 1066,66 
Total 1000 Total 3511.66 
Benefits – Costs 2511.66 
Benefits /Costs 3.51 
 
The clinical signs, for farms presenting them, consist of nasal discharge, infra orbital 
edema, moderate respiratory illness with conjunctivitis, tracheitis and renal impairment. 
According to table 3, we notice that AE positive seroprevalence is very high in both farms 
with and without clinical signs (80% and 80.33% respectively), which imply a clear no 
difference between farms concerning the symptomatically side and the onset of AE in 
breeding laying hens. According to table 4, we notice that all farms (100%) with egg drop 
rates varying between 5 and 15% present positive seroprevalence.  
However, only 57.14% of positive seroprevalence is recorded in farms with egg drop 
rates exceeding 15%. Results concerning serological analysis of the studied farms are 
presented in table 5. According to this table, 75% of farms are not subject to vaccination 
against the AE. Serological results revealed a percentage of 81.25% of positive 
seroconversion, namely in farms F1, F2, F3, F4, F5, F6, F7, F8, F9, F10, F11, F14 and F15.  
This seroconversion is clearly noticed by the increase of the number of antibodies 
in those farms in day 21 compared to day 1. The p-values resulting from the Mann-Whitney 
test corresponding to the 16 farms are presented in table 5. According to this table, we notice 
that, at 5% degree of significance, seven farms present significant p-values (those that are < 
0.05). This means that, in these farms, we reject the null hypothesis of median equality 
between the two serological samples and we statistically conclude that those samples do not 
have the same distribution. For economic analysis, results of costs-benefits analysis are 
presented in table 7. We notice from this table that vaccination against AE virus engenders 
much more economic benefits than costs. In other words, economic benefits of vaccination 
against AE are about 3.5 times much greater than costs of vaccination. 
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Given that all other viruses are subject to routine vaccination, AE is still not common 
and vaccination against it is not exhaustively applied in Algeria. This is very clear in our 
study since 75% of farms are not subject to vaccination against this virus, so positive 
serology implies necessarily the presence of AE in our farms. This is confirmed with Mann-
Whitney test results. In fact, since we surely know that samples of day 1 and day 21 come 
from the same population (the same farm for each two samples); the median inequality 
between the two samples is not due to the difference of distribution between them, but 
otherwise to the presence of AE virus in laying hens, which implies that the positive 
seroconversion in the previously mentioned farms is just the consequence of AE virus and is 
not a matter of different populations.  
Despite the positive seroconversion, atypical results may be noticed at farm level F1 
where there was a drop in the number of antibodies at the second sample compared to the 
first (table 5). This is due to the very late intervention on laying hens for the first sample 
phase in farm level F1. It followed therefore the image of a curve in the descending phase 
of the production of antibodies. It is very clear that AE strongly affects the production of egg 
for consumption and leads to serious economic losses due not only to the drop in production 
but also because of the resulting fragile and discoloured eggs. Vaccination against AE has 
clearly showed significant economic benefits especially in what concerns egg production 
gain, hen mortality reduction and hen treatment reduction. Indeed, this microeconomic 
financial approach allows the conclusion that it is strongly recommended to develop a 
systematic vaccination of chicken in Algeria. Such procedure would avoid losses estimated 
at 2511.66 € for each 10000 hens in case of clinical manifestation of AE. For comparison 
work, a lot of studies have been conducted to highlight the presence of AE as well as 
vaccination and vaccination effect. Freitas and Back (2015) demonstrated that clinical, 
histopathological, and serological evidences obtained in their study showed a significant 
increase of cases of avian encephalomyelitis in broilers from the last quarter of 2012 until 
the end of 2013. The cause of this increase was not clear, but vaccination failures were 
suspected. The monitoring of breeders before the beginning of egg production and the 
application of two vaccinations, if necessary, were suggested. Roy et al. (2009) showed the 
presence of AE through the diagnosis of the disease based on virus isolation in embryonated 
chicken’s eggs, demonstration of hexagonal virus particles in purkinje cells of cerebellum 
by electron microscopy and confirmation by agar gel immunodiffusion test using AE virus 
specific antiserum. Asasi et al. (2008) showed the presence of AE infection in broiler flocks 
around Shiraz (Iran) after an increase in serum encephalomyelitis virus antibody titer in 




Throughout this study, we conclude that avian encephalomyelitis (AE) virus is 
present in laying hen farms of Algeria and constitutes a leading risk factor for hen death as 
well as egg production drop. Without systematic vaccination against this virus, economic 
losses estimated at 2511.66 € may be encountered for each 10000 hens in case of clinical 
manifestation of the virus. 
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